Lactocitrate is a dialysis solution for continuous venovenose haemodialysis (CVVHD) with citrate anticoagulation of 4% trisodium citrate solution and with concomitant administration of calcium, i.e. for continual therapy of renal function. Lactocitrate can only be used in combination with a continuous haemodialysis device, which is also integrated with the citrate and calcium infusion pumps, in addition to the blood flow control pump, the dialysis solution and the filtrate. Lactocitrate is a solution.
Lactocitrate is supplied as a unicameral bag with a total volume of 5000ml. This medical device is intended for professional use only after proper training by the manufacturer.
Dialysis solution for immediate use includes:
For complete information, see the Package flyer.
|Sodium lactate||2.017 g/L|
|Sodium chloride||6.550 g/L|
|Potassium chloride||0.075 G/L|
|Magnesium chloride hexahydrate||0.305 g/L|
|Potassium dihydrogen phosphate||0.136 g/L|
Water for injections
The concentration of ions and glucose in the dialysis fluid for immediate use are:
|Mg+ +||1.5 mmol/L|
|Theoretical osmolarity||274 Mosmol/L|